dexmedetomidine has been researched along with Arteriosclerosis, Coronary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Li, F; Teng, J; Wang, W; Wang, Y; Yu, H | 1 |
| Chen, S; Cheng, H; Wang, J; Wu, J; Yang, X | 1 |
| El-Ashmawi Md, H; Elayashy Md Desa Fcai, M; Hosny, H; Mohamed, H; Tawadros Md, P | 1 |
| Balkanay, OO; Goksedef, D; Ipek, G; Omeroglu, SN | 1 |
| England, M; Herr, DL; Sum-Ping, ST | 1 |
3 trial(s) available for dexmedetomidine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effect of Dexmedetomidine Infusion on Sublingual Microcirculation in Patients Undergoing On-Pump Coronary Artery Bypass Graft Surgery: A Prospective Randomized Trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Microcirculation; Middle Aged; Mouth Floor; Postoperative Complications; Prospective Studies; Single-Blind Method; Treatment Outcome | 2019 |
The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Biomarkers; Blood Urea Nitrogen; Coronary Artery Bypass; Coronary Artery Disease; Creatinine; Cytoprotection; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Kidney; Lipocalin-2; Lipocalins; Male; Middle Aged; Predictive Value of Tests; Proto-Oncogene Proteins; Tertiary Care Centers; Time Factors; Treatment Outcome; Turkey | 2015 |
ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analgesics, Opioid; Anti-Arrhythmia Agents; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Canada; Conscious Sedation; Coronary Artery Bypass; Coronary Artery Disease; Dexmedetomidine; Diuretics; Female; gamma-Glutamyltransferase; Heart Rate; Humans; Hypnotics and Sedatives; Incidence; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Morphine; Postoperative Care; Postoperative Complications; Propofol; Respiration, Artificial; Systole; Time Factors; Treatment Outcome; United States; Vasodilator Agents | 2003 |
2 other study(ies) available for dexmedetomidine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effect of Dexmedetomidine on The Neuroglobin Expression in Elderly Patients With Minimally Invasive Coronary Artery Bypass Graft Surgery.
Topics: Aged; Analgesics, Non-Narcotic; China; Cognition; Coronary Artery Bypass; Coronary Artery Disease; Dexmedetomidine; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Incidence; Male; Minimally Invasive Surgical Procedures; Neuroglobin; Postoperative Cognitive Complications; Retrospective Studies | 2021 |
DEXMEDETOMIDINE AMELIORATES ACUTE BRAIN INJURY INDUCED BY MYOCARDIAL ISCHEMIA-REPERFUSION VIA UPREGULATING THE HIF-1 PATHWAY.
Topics: Animals; Brain Injuries; Coronary Artery Disease; Dexmedetomidine; Humans; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Reperfusion Injury; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2023 |